BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26876613)

  • 1. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention.
    Bridgeman BB; Wang P; Ye B; Pelling JC; Volpert OV; Tong X
    Cell Signal; 2016 May; 28(5):460-468. PubMed ID: 26876613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
    Tong X; Smith KA; Pelling JC
    Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.
    Xu S; Li L; Li M; Zhang M; Ju M; Chen X; Gu H
    Oxid Med Cell Longev; 2017; 2017():5930639. PubMed ID: 28400912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src kinase is a direct target of apigenin against UVB-induced skin inflammation.
    Byun S; Park J; Lee E; Lim S; Yu JG; Lee SJ; Chen H; Dong Z; Lee KW; Lee HJ
    Carcinogenesis; 2013 Feb; 34(2):397-405. PubMed ID: 23161610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin restores impairment of autophagy and downregulation of unfolded protein response regulatory proteins in keratinocytes exposed to ultraviolet B radiation.
    Li L; Li M; Xu S; Chen H; Chen X; Gu H
    J Photochem Photobiol B; 2019 May; 194():84-95. PubMed ID: 30933875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handelin protects human skin keratinocytes against ultraviolet B-induced photodamage via autophagy activation by regulating the AMPK-mTOR signaling pathway.
    Chu J; Xiang Y; Lin X; He M; Wang Y; Ma Q; Duan J; Sun S
    Arch Biochem Biophys; 2023 Jul; 743():109646. PubMed ID: 37225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival.
    Tu Y; Ji C; Yang B; Yang Z; Gu H; Lu CC; Wang R; Su ZL; Chen B; Sun WL; Xia JP; Bi ZG; He L
    Mol Cancer; 2013 Dec; 12(1):172. PubMed ID: 24365180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival.
    Carr TD; DiGiovanni J; Lynch CJ; Shantz LM
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1394-404. PubMed ID: 23129577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seawater pearl hydrolysate inhibits photoaging via decreasing oxidative stress, autophagy and apoptosis of Ultraviolet B-induced human skin keratinocytes.
    Han S; Liu P; Yan Q; Cen Y; Wu G; Chen Z; Li M; Deng Y; Luo F; Lin J
    J Cosmet Dermatol; 2024 Jan; 23(1):256-270. PubMed ID: 37435953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice.
    Wang F; Ma H; Liu Z; Huang W; Xu X; Zhang X
    Biomed Pharmacother; 2017 Aug; 92():672-680. PubMed ID: 28582759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy participates in isoliquiritigenin-induced melanin degradation in human epidermal keratinocytes through PI3K/AKT/mTOR signaling.
    Yang Z; Zeng B; Pan Y; Huang P; Wang C
    Biomed Pharmacother; 2018 Jan; 97():248-254. PubMed ID: 29091873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes.
    Syed DN; Afaq F; Mukhtar H
    Photochem Photobiol; 2012; 88(5):1184-90. PubMed ID: 22335604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.
    Tong X; Pelling JC
    Anticancer Agents Med Chem; 2013 Sep; 13(7):971-8. PubMed ID: 23272913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK.
    Kim A; Lee CS
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):271-283. PubMed ID: 29264665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures.
    Abu-Yousif AO; Smith KA; Getsios S; Green KJ; Van Dross RT; Pelling JC
    Cancer Res; 2008 Apr; 68(8):3057-65. PubMed ID: 18413777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells.
    Cao C; Lu S; Jiang Q; Wang WJ; Song X; Kivlin R; Wallin B; Bagdasarian A; Tamakloe T; Chu WM; Marshall J; Kouttab N; Xu A; Wan Y
    Cell Signal; 2008 Oct; 20(10):1830-8. PubMed ID: 18644433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1.
    Tong X; Mirzoeva S; Veliceasa D; Bridgeman BB; Fitchev P; Cornwell ML; Crawford SE; Pelling JC; Volpert OV
    Oncotarget; 2014 Nov; 5(22):11413-27. PubMed ID: 25526033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.